<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR101">
 <label>101.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Milligan</surname>
    <given-names>GN</given-names>
   </name>
   <name>
    <surname>White</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Zavala</surname>
    <given-names>D</given-names>
   </name>
   <name>
    <surname>Pyles</surname>
    <given-names>RB</given-names>
   </name>
   <name>
    <surname>Sarathy</surname>
    <given-names>VV</given-names>
   </name>
   <name>
    <surname>Barrett</surname>
    <given-names>ADT</given-names>
   </name>
   <name>
    <surname>Bourne</surname>
    <given-names>N</given-names>
   </name>
  </person-group>
  <article-title>Spectrum of activity testing for therapeutics against all four dengue virus serotypes in AG129 mouse models: proof-of-concept studies with the adenosine nucleoside inhibitor NITD-008</article-title>
  <source>Antivir Res</source>
  <year>2018</year>
  <volume>154</volume>
  <fpage>104</fpage>
  <lpage>109</lpage>
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2018.04.012</pub-id>
  <?supplied-pmid 29665374?>
  <pub-id pub-id-type="pmid">29665374</pub-id>
 </element-citation>
</ref>
